metastatic/advanced OC (mOC) - 1st line (L1) | ||
mOC - L1 - all population | mOC - L1 - PDL1 positive | |
atezolizumab plus SoC | IMagyn-050 ... | IMagyn-050 ... |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -